In an effort to better understand how conflicts of interest may affect health care, the New York Academy of Sciences is hosting a high-profile conference this coming June with panels featuring more than two dozen prominent academics and a smattering of people from industry, government, and the nonprofit world who will be encouraged to think big thoughts and parse nuanced scenarios.

But the event is generating something of a dustup as a handful of prospective panelists have declined to participate. In their view, the conference will be sullied by corporate sponsorship — Johnson & Johnson is underwriting the gathering — and there is concern the health care giant has a vested interest in managing and influencing how conflicts in the world of medicine are perceived and handled.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy